News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
EMSTER KURT VON
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/08/2023 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
01/27/2023 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
10/13/2022 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 30,250 shares
@ $0 |
|
03/23/2022 |
4
| EMSTER KURT VON (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 78,045 options to buy
@ $3.54, valued at
$276.3k
|
|
01/27/2022 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 67,000 options to buy
@ $2.94, valued at
$197k
|
|
10/01/2021 |
3
| EMSTER KURT VON (10% Owner) has filed a Form 3 on Jasper Therapeutics, Inc. |
06/03/2021 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Vaxcyte, Inc.
Txns:
| Granted 15,000 options to buy
@ $21.49, valued at
$322.4k
|
|
05/18/2021 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Bought 17,828 shares
@ $12.0404, valued at
$214.7k
Converted 2,187,504 shares
@ $0 Bought 772,727 shares
@ $11, valued at
$8.5M
Converted 2,187,504 preferred shares
@ $0 |
|
05/17/2021 |
4
| EMSTER KURT VON (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 9,925 options to buy
@ $11, valued at
$109.2k
|
|
05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/01/2021 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 32,000 options to buy
@ $5.78, valued at
$185k
|
|
06/23/2020 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 49,245 options to buy
@ $4.05, valued at
$199.4k
|
|
06/18/2020 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Vaxcyte, Inc.
Txns:
| Converted 2,185,415 shares
@ $0 Converted 1,217,074 shares
@ $0 Converted 454,812 shares
@ $0 Converted 298,917 shares
@ $0 Bought 12,500 shares
@ $16, valued at
$200k
Converted 2,185,415 preferred shares
@ $0 Converted 1,217,074 preferred shares
@ $0 Converted 454,812 preferred shares
@ $0 Converted 298,917 preferred shares
@ $0 |
|
06/16/2020 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on Vaxcyte, Inc.
Txns:
| Granted 40,000 options to buy
@ $16, valued at
$640k
|
|
06/15/2020 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Vaxcyte, Inc.
Txns:
| Granted 40,000 options to buy
@ $16, valued at
$640k
|
|
06/11/2020 |
3
| EMSTER KURT VON (Director) has filed a Form 3 on Vaxcyte, Inc. |
01/31/2019 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 27,705 options to buy
@ $8.43, valued at
$233.6k
|
|
01/18/2019 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Sold 62,925 shares
@ $29.7047, valued at
$1.9M
|
|
12/19/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Sold 3,009 shares
@ $33.1662, valued at
$99.8k
Sold 69,925 shares
@ $29.7047, valued at
$2.1M
|
|
12/19/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 88,889 shares
@ $8.17, valued at
$726.2k
Sold 53,492 shares
@ $7.4285, valued at
$397.4k
|
|
06/18/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Granted 15,000 options to buy
@ $59.31, valued at
$889.7k
|
|
06/11/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 920 shares
@ $12.51, valued at
$11.5k
Exercised (in-or-at-the-money) 2,000 warrants
@ $5.75, valued at
$11.5k
|
|
06/07/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 920 shares
@ $12.51, valued at
$11.5k
Exercised (in-or-at-the-money) 2,000 warrants
@ $5.75, valued at
$11.5k
|
|
06/07/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG |
06/07/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Sold 920 shares
@ $12.51, valued at
$11.5k
Exercised (in-or-at-the-money) 2,000 warrants
@ $5.75, valued at
$11.5k
|
|
05/15/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Sold 113,477 shares
@ $53.3565, valued at
$6.1M
Sold 127,890 shares
@ $52.4561, valued at
$6.7M
Sold 8,633 shares
@ $51.7264, valued at
$446.6k
Sold 116,247 shares
@ $56.8972, valued at
$6.6M
Sold 73,144 shares
@ $55.7219, valued at
$4.1M
Sold 126,901 shares
@ $54.9899, valued at
$7M
Sold 53,927 shares
@ $53.8613, valued at
$2.9M
Sold 20,881 shares
@ $52.9339, valued at
$1.1M
Sold 8,900 shares
@ $52.1955, valued at
$464.5k
|
|
03/07/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 13,353 shares
@ $15.51, valued at
$207.1k
|
|
02/20/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 68,712 shares
@ $14.49, valued at
$995.6k
|
|
02/16/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 162,979 shares
@ $13.69, valued at
$2.2M
|
|
02/15/2018 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 55,078 shares
@ $13.51, valued at
$744.1k
Sold 162,979 shares
@ $16.69, valued at
$2.7M
|
|
|
|
|